KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Cash from Operations: 2009-2025

Historic Cash from Operations for Colgate Palmolive (CL) over the last 17 years, with Sep 2025 value amounting to $1.3 billion.

  • Colgate Palmolive's Cash from Operations rose 8.05% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 billion, marking a year-over-year increase of 1.01%. This contributed to the annual value of $4.1 billion for FY2024, which is 9.67% up from last year.
  • According to the latest figures from Q3 2025, Colgate Palmolive's Cash from Operations is $1.3 billion, which was up 42.65% from $884.0 million recorded in Q2 2025.
  • In the past 5 years, Colgate Palmolive's Cash from Operations registered a high of $1.3 billion during Q4 2024, and its lowest value of $386.0 million during Q1 2022.
  • Moreover, its 3-year median value for Cash from Operations was $990.0 million (2024), whereas its average is $963.4 million.
  • As far as peak fluctuations go, Colgate Palmolive's Cash from Operations crashed by 39.15% in 2022, and later soared by 90.41% in 2023.
  • Quarterly analysis of 5 years shows Colgate Palmolive's Cash from Operations stood at $1.1 billion in 2021, then tumbled by 39.15% to $673.0 million in 2022, then spiked by 68.80% to $1.1 billion in 2023, then rose by 11.71% to $1.3 billion in 2024, then climbed by 8.05% to $1.3 billion in 2025.
  • Its Cash from Operations stands at $1.3 billion for Q3 2025, versus $884.0 million for Q2 2025 and $600.0 million for Q1 2025.